25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Allarity Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Allarity together

I guess you are interested in Allarity Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Allarity Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Allarity Therapeutics Inc

I send you an email if I find something interesting about Allarity Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Allarity (30 sec.)










1.2. What can you expect buying and holding a share of Allarity? (30 sec.)

How much money do you get?

How much money do you get?
$0.21
When do you have the money?
1 year
How often do you get paid?
43.8%

What is your share worth?

Current worth
$8.23
Expected worth in 1 year
$18.85
How sure are you?
43.8%

+ What do you gain per year?

Total Gains per Share
$10.83
Return On Investment
1,061.3%

For what price can you sell your share?

Current Price per Share
$1.02
Expected price per share
$0 - $1.32
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Allarity (5 min.)




Live pricePrice per Share (EOD)
$1.02
Intrinsic Value Per Share
$-133.60 - $-156.97
Total Value Per Share
$-125.37 - $-148.74

2.2. Growth of Allarity (5 min.)




Is Allarity growing?

Current yearPrevious yearGrowGrow %
How rich?$12.9m-$637.7k$6.5m110.8%

How much money is Allarity making?

Current yearPrevious yearGrowGrow %
Making money-$4.8m-$3.4m-$1.3m-28.1%
Net Profit Margin-1,242.2%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Allarity (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#589 / 944

Most Revenue
#690 / 944

Most Profit
#422 / 944

Most Efficient
#728 / 944
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Allarity?

Welcome investor! Allarity's management wants to use your money to grow the business. In return you get a share of Allarity.

First you should know what it really means to hold a share of Allarity. And how you can make/lose money.

Speculation

The Price per Share of Allarity is $1.02. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Allarity.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Allarity, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $8.23. Based on the TTM, the Book Value Change Per Share is $2.65 per quarter. Based on the YOY, the Book Value Change Per Share is $-2.05 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.05 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Allarity.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-7.71-756.1%-3.04-298.3%-3.86-378.2%-8.98-880.6%-8.98-880.6%
Usd Book Value Change Per Share-5.81-570.0%2.65260.3%-2.05-201.0%0.5150.4%0.5150.4%
Usd Dividend Per Share0.054.4%0.055.1%1.11108.5%0.4342.0%0.4342.0%
Usd Total Gains Per Share-5.77-565.6%2.71265.3%-0.94-92.4%0.9492.4%0.9492.4%
Usd Price Per Share2.11-0.79-2.33-1.71-1.71-
Price to Earnings Ratio-0.07--0.09--0.12--0.29--0.29-
Price-to-Total Gains Ratio-0.37--0.02-0.16-0.03-0.03-
Price to Book Ratio0.26--0.10--5.00--0.87--0.87-
Price-to-Total Gains Ratio-0.37--0.02-0.16-0.03-0.03-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.02
Number of shares980
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.050.43
Usd Book Value Change Per Share2.650.51
Usd Total Gains Per Share2.710.94
Gains per Quarter (980 shares)2,652.26924.12
Gains per Year (980 shares)10,609.033,696.50
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
12021040710599168120163686
24052081321208336240317382
360731220318175043604711078
480941627424266723806314774
51012520345303584041007818470
612146244063644100851209422166
714167284774253117661411025862
816198325484862134471612529558
918219366095471151281814133254
102023104067106080168092015636950

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.016.00.00.0%0.016.00.00.0%0.016.00.00.0%
Book Value Change Per Share2.02.00.050.0%4.08.00.033.3%6.08.02.037.5%6.08.02.037.5%6.08.02.037.5%
Dividend per Share2.00.02.050.0%7.00.05.058.3%7.00.09.043.8%7.00.09.043.8%7.00.09.043.8%
Total Gains per Share2.02.00.050.0%5.07.00.041.7%7.07.02.043.8%7.07.02.043.8%7.07.02.043.8%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Allarity Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---5.8142.655-319%-2.050-65%0.514-1231%0.514-1231%
Book Value Per Share--8.2274.188+96%-0.451+105%7.337+12%7.337+12%
Current Ratio--2.7471.255+119%0.317+766%0.877+213%0.877+213%
Debt To Asset Ratio--0.3640.874-58%1.049-65%0.684-47%0.684-47%
Debt To Equity Ratio--0.5720.282+103%1.674-66%0.982-42%0.982-42%
Dividend Per Share--0.0450.052-13%1.107-96%0.429-89%0.429-89%
Enterprise Value--14373857.820-1916974.819+113%-9946992.970+169%-991008.626+107%-991008.626+107%
Eps---7.712-3.043-61%-3.857-50%-8.982+16%-8.982+16%
Ev To Ebitda Ratio---0.292-0.054-81%0.654-145%0.195-250%0.195-250%
Ev To Sales Ratio--infinfnan%infnan%nannan%nannan%
Free Cash Flow Per Share---3.454-2.546-26%-2.392-31%-2.249-35%-2.249-35%
Free Cash Flow To Equity Per Share---0.3653.171-112%-0.362-1%1.335-127%1.335-127%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---156.968--------
Intrinsic Value_10Y_min---133.601--------
Intrinsic Value_1Y_max---10.089--------
Intrinsic Value_1Y_min---9.907--------
Intrinsic Value_3Y_max---34.613--------
Intrinsic Value_3Y_min---32.957--------
Intrinsic Value_5Y_max---64.318--------
Intrinsic Value_5Y_min---59.329--------
Market Cap1440903.000-131%3324857.8201418275.182+134%3291757.030+1%7470118.531-55%7470118.531-55%
Net Profit Margin----12.4220%-0%-3.1050%-3.1050%
Operating Margin----19.2500%-0%-4.8130%-4.8130%
Operating Ratio---20.355-100%-0%5.089-100%5.089-100%
Pb Ratio0.124-107%0.256-0.096+137%-4.997+2048%-0.869+439%-0.869+439%
Pe Ratio-0.033+52%-0.068-0.094+38%-0.124+81%-0.293+328%-0.293+328%
Price Per Share1.020-107%2.1100.794+166%2.330-9%1.708+24%1.708+24%
Price To Free Cash Flow Ratio-0.074+52%-0.153-0.119-22%-0.303+98%-0.416+173%-0.416+173%
Price To Total Gains Ratio-0.177+52%-0.366-0.016-96%0.155-336%0.025-1535%0.025-1535%
Quick Ratio--2.4901.155+116%0.188+1226%0.635+292%0.635+292%
Return On Assets---0.596-0.279-53%-0.255-57%-0.224-62%-0.224-62%
Return On Equity---0.937-0.255-73%-0.375-60%-0.385-59%-0.385-59%
Total Gains Per Share---5.7692.706-313%-0.943-84%0.943-712%0.943-712%
Usd Book Value--12964000.0005894250.000+120%-637750.000+105%11730562.500+11%11730562.500+11%
Usd Book Value Change Per Share---5.8142.655-319%-2.050-65%0.514-1231%0.514-1231%
Usd Book Value Per Share--8.2274.188+96%-0.451+105%7.337+12%7.337+12%
Usd Dividend Per Share--0.0450.052-13%1.107-96%0.429-89%0.429-89%
Usd Enterprise Value--14373857.820-1916974.819+113%-9946992.970+169%-991008.626+107%-991008.626+107%
Usd Eps---7.712-3.043-61%-3.857-50%-8.982+16%-8.982+16%
Usd Free Cash Flow---5443000.000-3954500.000-27%-3379750.000-38%-3747062.500-31%-3747062.500-31%
Usd Free Cash Flow Per Share---3.454-2.546-26%-2.392-31%-2.249-35%-2.249-35%
Usd Free Cash Flow To Equity Per Share---0.3653.171-112%-0.362-1%1.335-127%1.335-127%
Usd Market Cap1440903.000-131%3324857.8201418275.182+134%3291757.030+1%7470118.531-55%7470118.531-55%
Usd Price Per Share1.020-107%2.1100.794+166%2.330-9%1.708+24%1.708+24%
Usd Profit---12152000.000-4836500.000-60%-3477750.000-71%-5676437.500-53%-5676437.500-53%
Usd Revenue---56000.000-100%-0%14000.000-100%14000.000-100%
Usd Total Gains Per Share---5.7692.706-313%-0.943-84%0.943-712%0.943-712%
 EOD+3 -5MRQTTM+13 -24YOY+12 -225Y+13 -2410Y+13 -24

3.3 Fundamental Score

Let's check the fundamental score of Allarity Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.033
Price to Book Ratio (EOD)Between0-10.124
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than12.490
Current Ratio (MRQ)Greater than12.747
Debt to Asset Ratio (MRQ)Less than10.364
Debt to Equity Ratio (MRQ)Less than10.572
Return on Equity (MRQ)Greater than0.15-0.937
Return on Assets (MRQ)Greater than0.05-0.596
Total5/10 (50.0%)

3.4 Technical Score

Let's check the technical score of Allarity Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.722
Ma 20Greater thanMa 501.143
Ma 50Greater thanMa 1001.361
Ma 100Greater thanMa 2002.738
OpenGreater thanClose1.030
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Allarity Therapeutics Inc

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing oncology therapeutics using drug-specific companion diagnostics generated by its drug response predictor technology. Its drug candidates include Stenoparib, a poly-ADP-ribose polymerase inhibitor that is in Phase 2 clinical trials for ovarian cancer; Dovitinib, a pan- tyrosine kinase inhibitor for the treatment of renal cell carcinoma; IXEMPRA (ixabepilone), a selective microtubule inhibitor in phase 2 for the treatment of metastatic breast cancer; LiPlaCis, a liposomal formulation of cisplatin, which is in Phase 2 clinical trials for metastatic breast cancer; and 2X-111, a liposomal formulation of doxorubicin that is in Phase 2 clinical trials for metastatic breast cancer and glioblastoma multiforme. Allarity Therapeutics, Inc. has a collaboration with Detsamma Investments Pty. Ltd. to develop Deflexifol for the treatment of solid tumors. The company was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Fundamental data was last updated by Penke on 2024-12-04 06:24:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is just able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Allarity earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Allarity Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,242.2%+1,242.2%
TTM-1,242.2%YOY--1,242.2%
TTM-1,242.2%5Y-310.5%-931.6%
5Y-310.5%10Y-310.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.6%+108.6%
TTM-1,242.2%-221.4%-1,020.8%
YOY--207.4%+207.4%
5Y-310.5%-346.2%+35.7%
10Y-310.5%-470.4%+159.9%
4.3.1.2. Return on Assets

Shows how efficient Allarity is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • -59.6% Return on Assets means that Allarity generated $-0.60 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Allarity Therapeutics Inc:

  • The MRQ is -59.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -27.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-59.6%TTM-27.9%-31.7%
TTM-27.9%YOY-25.5%-2.4%
TTM-27.9%5Y-22.4%-5.5%
5Y-22.4%10Y-22.4%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-59.6%-11.6%-48.0%
TTM-27.9%-12.0%-15.9%
YOY-25.5%-11.2%-14.3%
5Y-22.4%-12.6%-9.8%
10Y-22.4%-14.1%-8.3%
4.3.1.3. Return on Equity

Shows how efficient Allarity is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • -93.7% Return on Equity means Allarity generated $-0.94 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Allarity Therapeutics Inc:

  • The MRQ is -93.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-93.7%TTM-25.5%-68.2%
TTM-25.5%YOY-37.5%+12.1%
TTM-25.5%5Y-38.5%+13.0%
5Y-38.5%10Y-38.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-93.7%-14.5%-79.2%
TTM-25.5%-16.0%-9.5%
YOY-37.5%-14.6%-22.9%
5Y-38.5%-18.5%-20.0%
10Y-38.5%-19.2%-19.3%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Allarity Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Allarity is operating .

  • Measures how much profit Allarity makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Allarity Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,925.0%+1,925.0%
TTM-1,925.0%YOY--1,925.0%
TTM-1,925.0%5Y-481.3%-1,443.8%
5Y-481.3%10Y-481.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.0%+204.0%
TTM-1,925.0%-316.8%-1,608.2%
YOY--215.6%+215.6%
5Y-481.3%-376.1%-105.2%
10Y-481.3%-480.3%-1.0%
4.3.2.2. Operating Ratio

Measures how efficient Allarity is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Allarity Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM20.355-20.355
TTM20.355YOY-+20.355
TTM20.3555Y5.089+15.266
5Y5.08910Y5.0890.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.284-2.284
TTM20.3553.198+17.157
YOY-3.247-3.247
5Y5.0894.651+0.438
10Y5.0896.419-1.330
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Allarity Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Allarity is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 2.75 means the company has $2.75 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Allarity Therapeutics Inc:

  • The MRQ is 2.747. The company is able to pay all its short-term debts. +1
  • The TTM is 1.255. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ2.747TTM1.255+1.492
TTM1.255YOY0.317+0.938
TTM1.2555Y0.877+0.379
5Y0.87710Y0.8770.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7473.586-0.839
TTM1.2553.869-2.614
YOY0.3174.644-4.327
5Y0.8775.971-5.094
10Y0.8776.240-5.363
4.4.3.2. Quick Ratio

Measures if Allarity is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • A Quick Ratio of 2.49 means the company can pay off $2.49 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Allarity Therapeutics Inc:

  • The MRQ is 2.490. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.155. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ2.490TTM1.155+1.335
TTM1.155YOY0.188+0.967
TTM1.1555Y0.635+0.520
5Y0.63510Y0.6350.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4903.093-0.603
TTM1.1553.392-2.237
YOY0.1884.304-4.116
5Y0.6355.953-5.318
10Y0.6356.435-5.800
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Allarity Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Allarity assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Allarity to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.36 means that Allarity assets are financed with 36.4% credit (debt) and the remaining percentage (100% - 36.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Allarity Therapeutics Inc:

  • The MRQ is 0.364. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.874. The company is just able to pay all its debts by selling its assets.
Trends
Current periodCompared to+/- 
MRQ0.364TTM0.874-0.510
TTM0.874YOY1.049-0.175
TTM0.8745Y0.684+0.190
5Y0.68410Y0.6840.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3640.346+0.018
TTM0.8740.347+0.527
YOY1.0490.313+0.736
5Y0.6840.365+0.319
10Y0.6840.383+0.301
4.5.4.2. Debt to Equity Ratio

Measures if Allarity is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Allarity to the Biotechnology industry mean.
  • A Debt to Equity ratio of 57.2% means that company has $0.57 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Allarity Therapeutics Inc:

  • The MRQ is 0.572. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.282. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.572TTM0.282+0.290
TTM0.282YOY1.674-1.392
TTM0.2825Y0.982-0.700
5Y0.98210Y0.9820.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5720.393+0.179
TTM0.2820.432-0.150
YOY1.6740.388+1.286
5Y0.9820.455+0.527
10Y0.9820.498+0.484
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Allarity generates.

  • Above 15 is considered overpriced but always compare Allarity to the Biotechnology industry mean.
  • A PE ratio of -0.07 means the investor is paying $-0.07 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Allarity Therapeutics Inc:

  • The EOD is -0.033. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.068. Based on the earnings, the company is expensive. -2
  • The TTM is -0.094. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.033MRQ-0.068+0.035
MRQ-0.068TTM-0.094+0.026
TTM-0.094YOY-0.124+0.030
TTM-0.0945Y-0.293+0.198
5Y-0.29310Y-0.2930.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.033-2.180+2.147
MRQ-0.068-2.507+2.439
TTM-0.094-3.153+3.059
YOY-0.124-3.242+3.118
5Y-0.293-5.992+5.699
10Y-0.293-6.690+6.397
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Allarity Therapeutics Inc:

  • The EOD is -0.074. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.153. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.119. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.074MRQ-0.153+0.079
MRQ-0.153TTM-0.119-0.033
TTM-0.119YOY-0.303+0.183
TTM-0.1195Y-0.416+0.297
5Y-0.41610Y-0.4160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.074-2.879+2.805
MRQ-0.153-3.276+3.123
TTM-0.119-3.669+3.550
YOY-0.303-4.485+4.182
5Y-0.416-8.015+7.599
10Y-0.416-9.197+8.781
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Allarity is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 0.26 means the investor is paying $0.26 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Allarity Therapeutics Inc:

  • The EOD is 0.124. Based on the equity, the company is cheap. +2
  • The MRQ is 0.256. Based on the equity, the company is cheap. +2
  • The TTM is -0.096. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD0.124MRQ0.256-0.132
MRQ0.256TTM-0.096+0.352
TTM-0.096YOY-4.997+4.901
TTM-0.0965Y-0.869+0.773
5Y-0.86910Y-0.8690.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD0.1241.964-1.840
MRQ0.2562.056-1.800
TTM-0.0962.388-2.484
YOY-4.9972.460-7.457
5Y-0.8693.697-4.566
10Y-0.8694.324-5.193
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Allarity Therapeutics Inc.

4.8.1. Institutions holding Allarity Therapeutics Inc

Institutions are holding 1.204% of the shares of Allarity Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-06-30Virtu Financial LLC0.19950.00392653382653380
2024-09-30UBS Group AG0.4162018452170781242.9403
2024-06-30Jane Street Group LLC0.0118015667156670
2024-09-30Tower Research Capital LLC0.07680.000234032998740.2469
2024-06-30Bank of America Corp0.000101451450
2024-09-30Headlands Technologies LLC000-1-100
2024-09-30Jump Financial LLC000-1293-100
2024-09-30Geode Capital Management, LLC000-3411-100
2024-06-30Citadel Advisors Llc000-1311-100
2024-09-30HRT FINANCIAL LLC000-1156-100
Total 0.70440.0041303005+294054+97.0%

4.9.2. Funds holding Allarity Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Fidelity Extended Market Index0.1653073273970118.2604
2024-09-30Fidelity Series Total Market Index0.03910173317330
2024-03-31Spartan Total Market Index Pool E00110
Total 0.204409061+5704+63.0%
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2023-09-302023-12-312024-03-312024-06-302024-09-30
Net Interest Income  -22-205-227125-102-271-373584211



5.2. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets20,378
Total Liabilities7,414
Total Stockholder Equity12,964
 As reported
Total Liabilities 7,414
Total Stockholder Equity+ 12,964
Total Assets = 20,378

Assets

Total Assets20,378
Total Current Assets20,366
Long-term Assets12
Total Current Assets
Cash And Cash Equivalents 18,463
Other Current Assets 1,903
Total Current Assets  (as reported)20,366
Total Current Assets  (calculated)20,366
+/-0
Long-term Assets
Property Plant Equipment 12
Long-term Assets  (as reported)12
Long-term Assets  (calculated)12
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities7,414
Long-term Liabilities0
Total Stockholder Equity12,964
Total Current Liabilities
Short-term Debt 1,337
Short Long Term Debt 1,337
Accounts payable 4,693
Other Current Liabilities 1,324
Total Current Liabilities  (as reported)7,414
Total Current Liabilities  (calculated)8,691
+/- 1,277
Long-term Liabilities
Long-term Liabilities  (as reported)0
Long-term Liabilities  (calculated)0
+/-0
Total Stockholder Equity
Retained Earnings -111,513
Accumulated Other Comprehensive Income -693
Other Stockholders Equity 125,170
Total Stockholder Equity (as reported)12,964
Total Stockholder Equity (calculated)12,964
+/-0
Other
Cash and Short Term Investments 18,463
Common Stock Shares Outstanding 1,576
Liabilities and Stockholders Equity 20,378
Net Debt -17,126
Net Invested Capital 14,301
Net Working Capital 12,952
Property Plant and Equipment Gross 12
Short Long Term Debt Total 1,337



5.3. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
33,403
0
0
36,987
49,633
49,633
23,194
23,194
14,544
12,702
13,426
13,875
11,862
11,969
30,883
20,378
20,37830,88311,96911,86213,87513,42612,70214,54423,19423,19449,63349,63336,9870033,4030
   > Total Current Assets 
0
1,715
12,851
55,400
7,635
21,054
21,054
10,119
10,082
4,968
2,966
3,686
4,387
1,971
2,295
21,309
20,366
20,36621,3092,2951,9714,3873,6862,9664,96810,08210,11921,05421,0547,63555,40012,8511,7150
       Cash And Cash Equivalents 
0
298
0
0
5,584
19,555
19,555
7,639
7,639
2,029
295
420
1,399
166
312
19,233
18,463
18,46319,2333121661,3994202952,0297,6397,63919,55519,5555,584002980
       Net Receivables 
0
1,124
10,191
13,606
1,806
1,345
1,345
1,432
1,433
871
1,333
1,603
1,632
946
1,331
1,579
0
01,5791,3319461,6321,6031,3338711,4331,4321,3451,3451,80613,60610,1911,1240
       Other Current Assets 
0
293
0
0
1
65
1,499
83
1,010
2,068
2,671
359
2,988
859
652
497
1,903
1,9034976528592,9883592,6712,0681,010831,499651002930
   > Long-term Assets 
0
31,688
0
0
29,352
28,579
28,579
13,112
13,112
9,576
9,736
9,740
9,488
9,891
9,674
9,574
12
129,5749,6749,8919,4889,7409,7369,57613,11213,11228,57928,57929,3520031,6880
       Property Plant Equipment 
0
352
1,047
884
117
94
94
47
47
27
25
26
29
20
18
17
12
1217182029262527474794941178841,0473520
       Long Term Investments 
0
845
0
0
491
350
314
254
0
0
0
0
0
0
0
0
0
000000000254314350491008450
       Intangible Assets 
0
30,491
0
0
28,744
28,135
28,135
12,811
12,811
9,549
9,711
9,714
9,459
9,871
9,656
9,557
0
09,5579,6569,8719,4599,7149,7119,54912,81112,81128,13528,13528,7440030,4910
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
3,266
0
0
0
0
0
000003,26600000000000
> Total Liabilities 
0
6,552
0
0
4,219
31,481
30,849
14,991
14,991
12,654
13,041
14,149
17,254
14,613
18,440
11,048
7,414
7,41411,04818,44014,61317,25414,14913,04112,65414,99114,99130,84931,4814,219006,5520
   > Total Current Liabilities 
0
5,533
36,255
43,713
3,838
20,719
20,719
11,462
11,191
11,222
11,588
12,668
15,744
14,167
18,008
10,616
7,414
7,41410,61618,00814,16715,74412,66811,58811,22211,19111,46220,71920,7193,83843,71336,2555,5330
       Short-term Debt 
0
1,520
0
0
98
0
98
0
54
2,652
2,687
350
0
1,300
2,690
1,325
1,337
1,3371,3252,6901,30003502,6872,65254098098001,5200
       Short Long Term Debt 
0
1,411
0
0
0
0
0
0
0
2,644
2,687
350
0
1,300
2,690
1,325
1,337
1,3371,3252,6901,30003502,6872,64400000001,4110
       Accounts payable 
0
2,116
13,494
14,191
739
698
698
5,555
5,555
6,251
6,449
8,089
6,347
8,416
11,058
7,753
4,693
4,6937,75311,0588,4166,3478,0896,4496,2515,5555,55569869873914,19113,4942,1160
       Other Current Liabilities 
0
1,897
11,257
28,543
3,001
11,333
11,273
4,424
5,582
2,319
2,452
2,272
3,022
4,392
4,217
1,481
1,324
1,3241,4814,2174,3923,0222,2722,4522,3195,5824,42411,27311,3333,00128,54311,2571,8970
   > Long-term Liabilities 
0
1,019
0
0
381
10,762
10,130
3,800
3,800
1,432
1,453
1,481
1,510
446
432
432
0
04324324461,5101,4811,4531,4323,8003,80010,13010,762381001,0190
       Warrants
0
0
0
0
0
0
0
0
0
2,003
0
0
0
0
0
0
0
00000002,003000000000
       Other Liabilities 
0
0
0
0
0
9,142
700
656
619
349
0
343
0
0
0
0
0
0000034303496196567009,14200000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
1,432
0
0
0
0
0
0
0
00000001,432000000000
> Total Stockholder Equity
0
26,851
0
0
32,768
18,152
18,784
8,203
8,203
1,890
-339
-723
-3,379
-2,751
-6,471
19,835
12,964
12,96419,835-6,471-2,751-3,379-723-3391,8908,2038,20318,78418,15232,7680026,8510
   Common Stock
0
1,624
11,952
18,259
3,157
810
810
1
929
2
0
-5,637
0
0
0
3
0
03000-5,6370292918108103,15718,25911,9521,6240
   Retained Earnings Total Equity0000000-82,550000000000
   Accumulated Other Comprehensive Income 
0
1,375
0
0
-419
0
-600
0
-1,632
-721
-637
-666
-758
-411
-386
-530
-693
-693-530-386-411-758-666-637-721-1,6320-6000-419001,3750
   Capital Surplus 
0
0
0
0
0
0
0
0
0
83,156
0
0
0
0
0
0
0
000000083,156000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
61,284
388
429
73,448
-600
84,434
-1,228
81,019
83,156
83,437
82,588
88,366
90,369
90,699
120,285
125,170
125,170120,28590,69990,36988,36682,58883,43783,15681,019-1,22884,434-60073,44842938861,2840



5.4. Balance Sheets

Currency in USD. All numbers in thousands.




5.5. Cash Flows

Currency in USD. All numbers in thousands.




5.6. Income Statements

Currency in USD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-37
Gross Profit-37-37
 
Operating Income (+$)
Gross Profit-37
Operating Expense-17,892
Operating Income-17,929-17,929
 
Operating Expense (+$)
Research Development7,866
Selling General Administrative10,026
Selling And Marketing Expenses0
Operating Expense17,89217,892
 
Net Interest Income (+$)
Interest Income30
Interest Expense-498
Other Finance Cost-114
Net Interest Income-354
 
Pretax Income (+$)
Operating Income-17,929
Net Interest Income-354
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-12,618-23,240
EBIT - interestExpense = -12,618
-12,618
-11,403
Interest Expense498
Earnings Before Interest and Taxes (EBIT)-12,120-12,120
Earnings Before Interest and Taxes (EBITDA)-12,083
 
After tax Income (+$)
Income Before Tax-12,618
Tax Provision--303
Net Income From Continuing Ops-13,017-12,315
Net Income-11,901
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses17,929
Total Other Income/Expenses Net5,311354
 

Technical Analysis of Allarity
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Allarity. The general trend of Allarity is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Allarity's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Allarity Therapeutics Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.15 < 1.29 < 1.32.

The bearish price targets are: .

Tweet this
Allarity Therapeutics Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Allarity Therapeutics Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Allarity Therapeutics Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Allarity Therapeutics Inc. The current macd is -0.12818725.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Allarity price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Allarity. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Allarity price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Allarity Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) ChartAllarity Therapeutics Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Allarity Therapeutics Inc. The current adx is 27.81.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Allarity shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Allarity Therapeutics Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Allarity Therapeutics Inc. The current sar is 1.11327706.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Allarity Therapeutics Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Allarity Therapeutics Inc. The current rsi is 30.72. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Allarity Therapeutics Inc Daily Relative Strength Index (RSI) ChartAllarity Therapeutics Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Allarity Therapeutics Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Allarity price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Allarity Therapeutics Inc Daily Stochastic Oscillator ChartAllarity Therapeutics Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Allarity Therapeutics Inc. The current cci is -95.56184495.

Allarity Therapeutics Inc Daily Commodity Channel Index (CCI) ChartAllarity Therapeutics Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Allarity Therapeutics Inc. The current cmo is -39.98605844.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Allarity Therapeutics Inc Daily Chande Momentum Oscillator (CMO) ChartAllarity Therapeutics Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Allarity Therapeutics Inc. The current willr is -93.10344828.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Allarity Therapeutics Inc Daily Williams %R ChartAllarity Therapeutics Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Allarity Therapeutics Inc.

Allarity Therapeutics Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Allarity Therapeutics Inc. The current atr is 0.09995785.

Allarity Therapeutics Inc Daily Average True Range (ATR) ChartAllarity Therapeutics Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Allarity Therapeutics Inc. The current obv is -25,894,394.

Allarity Therapeutics Inc Daily On-Balance Volume (OBV) ChartAllarity Therapeutics Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Allarity Therapeutics Inc. The current mfi is 42.41.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Allarity Therapeutics Inc Daily Money Flow Index (MFI) ChartAllarity Therapeutics Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Allarity Therapeutics Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-29STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-07-31MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-01MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-12MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-08-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-08-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-10MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-13RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-17STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-09-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-25RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-03STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-10-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-09STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-10-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-15RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-10-16SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-22DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-28MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-10-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-31WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-11-14DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-19RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-21RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-12-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-03MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-12-04RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-12-06MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-12-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-12-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-12-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Allarity Therapeutics Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Allarity Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.722
Ma 20Greater thanMa 501.143
Ma 50Greater thanMa 1001.361
Ma 100Greater thanMa 2002.738
OpenGreater thanClose1.030
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Allarity with someone you think should read this too:
  • Are you bullish or bearish on Allarity? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Allarity? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Allarity Therapeutics Inc

I send you an email if I find something interesting about Allarity Therapeutics Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Allarity Therapeutics Inc.

Receive notifications about Allarity Therapeutics Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.